Key statistics
On Wednesday, CERo Therapeutics Holdings Inc (CERO:NMQ) closed at 0.107, 48.20% above the 52 week low of 0.0722 set on Sep 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.098 |
---|---|
High | 0.112 |
Low | 0.0938 |
Bid | 0.1032 |
Offer | 0.104 |
Previous close | 0.098 |
Average volume | 11.81m |
---|---|
Shares outstanding | 51.58m |
Free float | 40.54m |
P/E (TTM) | -- |
Market cap | 5.52m USD |
EPS (TTM) | -0.3796 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 21:00 BST.
More ▼
Announcements
- CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
- CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236
- CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024
- CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
- CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
- CERo Therapeutics, Inc. Provides Corporate Update for Shareholders
More ▼